Authors


Cheri N. Frey, MD

Latest:

Cheri Frey, MD, FAAD: Exploring Cosmeceutical Ingredients and Their Role in Skin Health

Frey discussed the role of various cosmeceuticals and ingredients in benefitting the skin health of patients, as well as insights into pairing OTC products with Rx.


Steve Feldman, MD, PhD

Latest:

Ensure Patient Adherence in Pediatric Atopic Dermatitis Cases

Steve Feldman, MD, PhD, is part of an atopic dermatitis panel and focuses on strategies to hold pediatric patients and their parents accountable to treatment methods.


Brittany Scurto, PA-C

Latest:

Brittany Scurto, PA-C: How to Discuss an Integrative Medicine Approach With Patients

Scurto presented integrative medicine pearls at the 2024 Diversity in Dermatology meeting.



Kamran H. Imam, MD

Latest:

Award Recipient to Focus on Atopic Dermatitis in Native Americans

Kamran H. Imam, MD, hopes to unlock insights into the atopic disease burden among Native American populations.



Logan Lutton

Latest:

Majority of state medical boards see increase in COVID-19 misinformation complaints against physicians

An alarming amount of COVID-19 disinformation is prevalent even from physicians.


Matthew Gavidia

Latest:

Study: Lifestyle Behaviors Linked With Psoriasis Development

Lifestyle behaviors, such as body mass index and smoking, were shown to have a stronger association with psoriasis, regardless of genetic risk.


Laura Ferris, MD, PhD

Latest:

Frontline Forum Part 4: Solutions in the Management and Treatment of Basal Cell Carcinoma

In part 4 of this Frontline Forum series, John M. Strasswimmer, MD, PhD; Andrew H. Weinstein, MD; Neal Bhatia, MD; Laura Ferris, MD; and Aaron S. Farberg, MD, discuss solutions for managing and treating patients with basal cell carcinoma.


Michael Cameron, MD, FAAD

Latest:

Safety and Access Considerations: Topical Ruxolitinib Review

Dr Linda Stein-Gold and Dr Michael Cameron assess the safety and tolerability of topical ruxolitinib cream, offering guidance on counseling patients about the black box warning. They also address the perception of limited treatment access and strategies for overcoming this barrier.


Adel Haque, MD

Latest:

Managing Atopic Dermatitis Postpartum and While Breastfeeding

A patient returns to your clinic seeking systemic therapy for her AD while postpartum and breastfeeding. Test your knowledge on injectables.


Shawn Kwatra, MD

Latest:

Late-Breaking Data: Povorcitinib Significantly Improves Itch and Lesions in Prurigo Nodularis

Shawn Kwatra, MD, shares positive updates on phase 2 oral povorcitinib for prurigo nodularis at AAD 2024.


Jeff Bendix

Latest:

Burnout, Frustration Levels Continue to Grow Among Physicians

Doctors cite more support staff, reduced patient panels among solutions.


Terri L. Phillips, MD, FAAP

Latest:

Diverse Perspectives in Medical Aesthetics Matter More Than Ever

Dermatology Times® invites medical professionals in the dermatology community to speak out on the vital issues facing the specialty.



Stephen Zander, MBA

Latest:

How Can AI Improve Patient Care?

AI’s ability to quickly process and interpret large quantities of health data is a valuable tool for physicians.


Susan C. Olmstead, Editor

Latest:

Drug Combination May Benefit Patients with Transplanted Kidneys, Advanced Skin Cancers

In most kidney transplant recipients with advanced skin cancer, 2 checkpoint inhibitors are needed to boost the immune system, according to a new study.



Hope Mitchell, MD, FAAD

Latest:

Dermatology Times in France: What La Roche-Posay Products Dermatologists Recommend for Eczema, Acne

Dermatologists Jeanine Downie, DiAnne Davis, and Hope Mitchell reveal the La Roche-Posay products they recommend to patients with dry skin, eczema, and more, at the flagship store in France.


Daniel Siegel, MD

Latest:

Managing Dermatologic Surgery Challenges

Daniel Siegel, MD, shared strategies to manage surgery challenges, especially bleeding, to ensure a smooth experience for patients.


Gianna Melillo

Latest:

Study Underscores Need for More Effective Psoriasis Oral Therapies

Survey responses revealed the rates and times at which patients switched from oral to biologic therapies.


Nicholas Wrigley

Latest:

Data Support the Use of First-/Second-Line Immune Checkpoint Inhibitors in HNSCC

Findings from a retrospective cohort study found that immune checkpoint inhibitors induced promising responses in the first- and second-line treatment of head and neck squamous cell carcinoma.


Hadar Lev-Tov, MD

Latest:

Dermatologist Talks About the ABCs of Wounds and HS Support at Annual Meeting

Expert insights on the latest issues in wounds as well as HS resources are shared at the annual meeting.


Jeffrey Yager, MD

Latest:

Holistic Aesthetics Center to Host First Annual Symposium in Middletown, New York

Jeffrey Yager, MD, discusses the new SY Aesthetics campus that will integrate traditional and Chinese healing.


Sandra Fyfe

Latest:

Frontline Forum Part 4: Solutions in the Management and Treatment of Basal Cell Carcinoma

In part 4 of this Frontline Forum series, John M. Strasswimmer, MD, PhD; Andrew H. Weinstein, MD; Neal Bhatia, MD; Laura Ferris, MD; and Aaron S. Farberg, MD, discuss solutions for managing and treating patients with basal cell carcinoma.


Maggie L. Shaw

Latest:

Novel, Nonsurgical BCC Treatment Shown Safe and Effective

In this study, researchers treated 37 basal cell carcinoma (BCC) lesions from 30 patients, with follow-ups at 5 time points after baseline examination.


Michael Rubio, PA-C

Latest:

Is Your Texting as Caring as Your Bedside Manner?

Test your knowledge to see if your patients would consider you an efficient texter.


Sponsored by ASLAN Pharmaceuticals

Latest:

The Crystal Ball: What This Means for the Future of Atopic Dermatitis Treatments

Peter Lio, MD, reflects on current unmet needs in atopic dermatitis and suggests directions for future research and development.


Heather Raglin, Editor

Latest:

The Many Considerations of Managing Generalized Pustular Psoriasis

Experts discuss the treatment landscape of generalized pustular psoriasis as well as review difficult cases of GPP.


Jerry Brewer, MD, MS, FACMS

Latest:

When to Call a Time Out on Mohs Surgery

Jerry Brewer, MD, MS, shared pearls on reasons to avoid or discontinue Mohs surgery and keeping calm with stressed, vulnerable patients.

© 2024 MJH Life Sciences

All rights reserved.